RDY vs. JNJ
RDY (Dr. Reddy's Laboratories Limited) and JNJ (Johnson & Johnson) are both stocks. Both are in the Healthcare sector — RDY in Drug Manufacturers - Specialty & Generic, JNJ in Drug Manufacturers - General. Over the past 10 years, RDY returned 4.30%/yr vs 9.99%/yr for JNJ. At a 0.22 correlation, their price movements are largely independent.
Performance
RDY vs. JNJ - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, RDY achieves a -5.70% return, which is significantly lower than JNJ's 11.48% return. Over the past 10 years, RDY has underperformed JNJ with an annualized return of 4.30%, while JNJ has yielded a comparatively higher 9.99% annualized return.
RDY
- 1D
- 1.69%
- 1M
- -0.15%
- YTD
- -5.70%
- 6M
- -6.36%
- 1Y
- -9.68%
- 3Y*
- 6.43%
- 5Y*
- -0.73%
- 10Y*
- 4.30%
JNJ
- 1D
- 2.21%
- 1M
- 1.74%
- YTD
- 11.48%
- 6M
- 13.94%
- 1Y
- 52.64%
- 3Y*
- 16.30%
- 5Y*
- 9.61%
- 10Y*
- 9.99%
RDY vs. JNJ - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
RDY Dr. Reddy's Laboratories Limited | -5.70% | -10.53% | 14.13% | 36.47% | -19.74% | -7.33% | 76.80% | 8.45% | 0.37% | -16.46% |
JNJ Johnson & Johnson | 11.48% | 47.48% | -4.81% | -8.58% | 5.97% | 11.44% | 10.82% | 16.22% | -5.13% | 24.43% |
Correlation
The correlation between RDY and JNJ is 0.18, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.18 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.13 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.16 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.18 |
Correlation (All Time) Calculated using the full available price history since Apr 12, 2001 | 0.22 |
Fundamentals
RDY:
$11.05B
JNJ:
$557.92B
RDY:
$51.45
JNJ:
$8.65
RDY:
0.26
JNJ:
26.38
RDY:
0.01
JNJ:
0.88
RDY:
0.03
JNJ:
5.76
RDY:
0.03
JNJ:
6.87
RDY:
$337.10B
JNJ:
$96.36B
RDY:
$177.79B
JNJ:
$66.60B
RDY:
$74.65B
JNJ:
$31.62B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
RDY vs. JNJ — Risk / Return Rank
RDY
JNJ
RDY vs. JNJ - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Dr. Reddy's Laboratories Limited (RDY) and Johnson & Johnson (JNJ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| RDY | JNJ | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -3.57 | ||
| Sortino ratioReturn per unit of downside risk | -5.01 | ||
| Omega ratioGain probability vs. loss probability | 0.95 | 1.57 | -0.62 |
| Calmar ratioReturn relative to maximum drawdown | -0.43 | 4.83 | -5.26 |
| Martin ratioReturn relative to average drawdown | -0.74 | 14.43 | -15.18 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| RDY | JNJ | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -0.41 | 3.16 | -3.57 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.03 | 0.57 | -0.60 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.16 | 0.54 | -0.38 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.36 | 0.54 | -0.18 |
Drawdowns
RDY vs. JNJ - Drawdown Comparison
The maximum RDY drawdown since its inception was -60.62%, which is greater than JNJ's maximum drawdown of -50.67%. Use the drawdown chart below to compare losses from any high point for RDY and JNJ.
Loading charts...
Drawdown Indicators
| RDY | JNJ | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -60.62% | -50.67% | -9.95% |
Max Drawdown (1Y)Largest decline over 1 year | -22.46% | -10.96% | -11.50% |
Max Drawdown (3Y)Largest decline over 3 years | -26.61% | -15.95% | -10.66% |
Max Drawdown (5Y)Largest decline over 5 years | -35.25% | -18.41% | -16.84% |
Max Drawdown (10Y)Largest decline over 10 years | -47.13% | -27.37% | -19.76% |
Current DrawdownCurrent decline from peak | -20.90% | -7.68% | -13.22% |
Average DrawdownAverage peak-to-trough decline | -21.93% | -11.88% | -10.05% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 13.05% | 3.66% | +9.39% |
Volatility
RDY vs. JNJ - Volatility Comparison
Dr. Reddy's Laboratories Limited (RDY) has a higher volatility of 9.51% compared to Johnson & Johnson (JNJ) at 5.62%. This indicates that RDY's price experiences larger fluctuations and is considered to be riskier than JNJ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| RDY | JNJ | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 9.51% | 5.62% | +3.89% |
Volatility (6M)Calculated over the trailing 6-month period | 17.50% | 12.35% | +5.15% |
Volatility (1Y)Calculated over the trailing 1-year period | 23.85% | 16.77% | +7.08% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 23.29% | 16.85% | +6.44% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 26.60% | 18.45% | +8.15% |
Dividends
RDY vs. JNJ - Dividend Comparison
RDY's dividend yield for the trailing twelve months is around 0.69%, less than JNJ's 2.30% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
JNJ Johnson & Johnson | 2.30% | 2.48% | 3.40% | 3.00% | 2.52% | 2.45% | 2.53% | 2.57% | 2.74% | 2.38% | 2.73% | 2.87% |
RDY Dr. Reddy's Laboratories Limited | 0.69% | 0.65% | 0.60% | 1.39% | 1.48% | 1.04% | 0.46% | 0.71% | 0.00% | 0.78% | 0.62% | 0.63% |
Financials
RDY vs. JNJ - Financials Comparison
This section allows you to compare key financial metrics between Dr. Reddy's Laboratories Limited and Johnson & Johnson. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
RDY vs. JNJ - Profitability Comparison
RDY - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Dr. Reddy's Laboratories Limited reported a gross profit of 34.22B and revenue of 76.33B. Therefore, the gross margin over that period was 44.8%.
JNJ - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Johnson & Johnson reported a gross profit of 17.20B and revenue of 24.06B. Therefore, the gross margin over that period was 71.5%.
RDY - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Dr. Reddy's Laboratories Limited reported an operating income of 473.25M and revenue of 76.33B, resulting in an operating margin of 0.6%.
JNJ - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Johnson & Johnson reported an operating income of 6.40B and revenue of 24.06B, resulting in an operating margin of 26.6%.
RDY - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Dr. Reddy's Laboratories Limited reported a net income of 2.24B and revenue of 76.33B, resulting in a net margin of 2.9%.
JNJ - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Johnson & Johnson reported a net income of 5.24B and revenue of 24.06B, resulting in a net margin of 21.8%.
Frequently Asked Questions
RDY and JNJ have a correlation of 0.18, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
RDY has higher volatility (9.51%) compared to JNJ (5.62%). In terms of maximum drawdown, RDY dropped -60.62% vs JNJ's -50.67%.
JNJ currently has the higher Sharpe Ratio (3.16 vs -0.41), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for RDY and JNJ
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer